Smart Immune and Greater Paris University Hospitals (AP-HP) Begin Groundbreaking Phase I/II Trial with ProTcellTM, a Thymus-Empowered T Cell Therapy Platform, in Adults with Blood Cancers

Smart Immune SAS announced that SMART102, a human T-lymphoid progenitor cell injection derived from cord blood using SmartImmune’s ProTcell™ platform, has entered clinical testing in a trial sponsored and led by Great Paris University Hospitals.